19 results
10-K
2023 FY
EX-4.4
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought.
Transfer Agent and Registrar
American
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
trial participants;
costs of related litigation;
substantial monetary awards to patients and others;
increased cost of liability insurance;
loss … certain types of sensitive information, regulatory penalties, other legal proceedings such as but not limited to private litigation, the incurrence
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
the defense, settlement, negotiations or litigation relating to that portion of the Claim at the sole cost of the other Party, provided
8-K
EX-1.1
MIRA
Mira Pharmaceuticals Inc
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
or incomplete.
2.16. Litigation; Governmental Proceedings. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation … or governmental litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future
424B4
blab7agkplh44
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
ick86sqs1cg 9fk
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-10.3
ogzhwx
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.5
ah1zmvb50y
29 Jun 23
IPO registration
4:39pm
S-1
46lmhd8
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.5
79oec5
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-10.5
mqq7dw di
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
q4lwr3s7o4ws9v2
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
uxjfpg2x
2 May 23
Draft registration statement (amended)
12:00am
DRS
hyg1ff9
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next